CD4 and COVID-19: Within this adjusted experimental setup, we observed a noteworthy pattern: the COVID‐19 group exhibited an increased presence of IFN‐γ (+) CD4 and TNF‐α (+) CD4 cells compared to the control (Figure 2F,G).